Analyst consensus rating
Nephros Analyst Rating: Buy
Direct answer
Nephros's consensus rating is Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $6.08.
Forecast evidence checked November 10, 2026.
Get free Nephros email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.15
- Average price target
- $6.08
- High price target
- $8.00
- Low price target
- $4.25
- Low target gap
- +34.9%
- Target upside
- +93.1%
- High target gap
- +154%
- Target range width
- 119%
- Consensus rating
- Buy
- Analysts
- 3
- Evidence date
- November 10, 2026
- Valid through
- November 17, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Nephros?
Nephros has a verified Buy consensus. The same dataset has an average price target of $6.08.
How far are Nephros's low and high targets from the recorded price?
The low target implies +34.9%, while the high target implies +154%.
How many analysts are included in Nephros's consensus?
The verified consensus includes 3 analysts.
How is Nephros's target upside or downside calculated?
The average target of $6.08 is divided by the recorded price of $3.15, then one is subtracted to produce +93.1%. This does not guarantee a future return.
When was Nephros's analyst forecast verified?
The data was verified on 2026-11-10. The dataset is valid through 2026-11-17.